Shaping the Future with Breakthrough Technologies in Healthcare
March 4, 2026 @ 10:00 – 12:00 CET
Breakthrough Technologies in Molecular Life Science to Power Precision Medicine and the Future of Healthcare in Sweden
You are warmly invited to a dialogue event with the aim of bringing together healthcare, academia, industry, and other stakeholders to explore a national initiative for the future of translational healthcare in Sweden.
By 2035, Sweden has the ambition to become a world leader in translating breakthrough biotechnology and AI into patient-centered healthcare. This event will discuss the vision for an excellence cluster that integrates SciLifeLab cutting-edge molecular life science technologies with AI-driven data analysis at university hospitals across the country. At its core are joint units where clinicians, researchers, and technology experts work side by side to accelerate diagnosis, personalize treatment, and enable data-driven clinical decision support.
During the event, we will present the preparatory project, outline a national collaboration between research infrastructure, healthcare systems, and industry. The event will also address how this initiative can strengthen Sweden’s competitiveness, attract investment and deliver benefits for patients and society.
We look forward to welcoming you to a forward-looking dialogue on how together we can transform healthcare through breakthrough technologies and AI.
Read more about SciLifeLabs work within translation to healthcare here.
Program
| 09:30 | Coffee for onsite participants – outside “Torsten Wiesel” Karolinska university Hospital, Solnavägen 30, Solna |
| 10:00 | Introduction – Jan Ellenberg, Director SciLifeLab – Mia Phillipson, Co-Director SciLifeLab |
| 10:10 | Stakeholder Reflections – Annika Östman Wernerson, President Karolinska Institutet – Mathias Axelsson, Managing director medical diagnostics, Karolinska University Hospital |
| 10:20 | Key objectives for translation to healthcare – data, technology & innovation Valtteri Wirta, Päivi Östling, Per Lek |
| 10:50 | Examples from translational projects – When symptoms are vague, proteins can point the way, Mikael Åberg, Uppsala University, Axel Rosell, Karolinska Institutet and Charlotte Thålin, Karolinska Institutet – Predicting response to immunotherapy and antibody-drug conjugate therapy using Spatial Proteomics, Charlotte Stadler, KTH and Anders Ullén, Karolinska Institutet |
| 11:15 | Panel discussion – Q&A |
| 11:45 | Summary & Next steps |
| 12:00 | Light lunch for on-site participants |
Google Calendar 
